NJ Top Docs has reviewed and approved board-certified orthopedic surgeons, Brian Mehling, MD and Pavel Yufit, MD of Mehling Orthopedics for 2022. Both are fellows of the American Academy of Orthopedic Surgeons and specialize in trauma treatment. They are also members of the Orthopaedic Trauma Association. Their practice, Mehling Orthopedics is an orthopedic trauma practice … Continued
ZURICH, Switzerland – May 4, 2022 – Brian Mehling, MD, a world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, board-certified in anti-aging medicine, and founder of Blue Horizon International (BHI), will be attending the Annual World Economic Forum (WEF) in Davos from May 22-26. This will be Dr. Mehling’s ninth year attending the global conference. … Continued
Brian Mehling, M.D. and Pavel Yufit, M.D., orthopedic surgeons with practices in New York and New Jersey, are scheduled to attend the 2022 Annual Meeting of the American Academy of Orthopaedic Surgeons in Chicago, Illinois from March 22-26, 2022 at the McCormick Place Convention Center. The booth number is 1904. This is the world’s largest … Continued
Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy meeting being held in LA March 10-13 Brian Mehling, MD, founder and chief medical officer of BHI Therapeutic Sciences, will virtually present on three topics at the 19th Annual World Congress of Society for Brain Mapping and Therapeutics. The meeting, entitled Breaking Boundaries of Science, … Continued
Doreen Santora, RN, MHA, chief executive officer of Blue Horizon International (BHI) and its subsidiaries, including BHI Therapeutic Sciences, recently participated the Joint Commission International (JCI) program titled Managing Patient Safety Events: A Root Cause Analysis Workshop. The two-day, live virtual workshop provided participants with the knowledge, skills, and strategies to establish a standardized approach … Continued
Brian Mehling, MD has successfully completed all components of the Board Certification in the field of Anti-Aging and Regenerative Medicine. Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He spearheads groundbreaking research in stem cell … Continued
Brian Mehling, M.D., M.S.founder and chief medical officer of Blue Horizon International (BHI) and his team traveled to Monaco and Paris, France in November 2021, attending a series of meetings with potential investors and partners to expand access to stem cell therapeutics.BlueHorizonStemCells #StemCellTherapy #Monaco #France
Brian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center, CA from August 31- September 3, 2021.AAOS is the world’s largest meeting of orthopaedic surgeons, researchers, and allied health professionals.Dr. Mehling is the chief medical officer at BHI Therapeutic Sciences, LLC, … Continued
World leading translational neuroscience foundation highlighted the pioneering scientific, technological, advocacy, and policy work at the Ritz Carlton/JW Marriott in Downtown LA on July 10, 2021 The conference was the first in-person major medical conference in California after the state reopened.Dr. Brian Mehling is the founder and chief medical officer of BHI Therapeutic Sciences. He … Continued